vistagen.com (VTGN) - Bozor qiymatining balans qiymatiga nisbati
Vistagen Therapeutics (VTGN) moslashuvchan yondashuv va istiqbolli aksiyalar opsionlari orqali yetakchi neyrobiologiya mutaxassislarini jalb qilmoqda. Ushbu narxlar grafigi kompaniyaning xavotirni bartaraf etuvchi, tez ta'sir qiluvchi va bog'liqlikni keltirib chiqarmaydigan burun orqali yuboriladigan davolash vositalarini ishlab chiqish dinamikasini aks ettiradi. Shu bilan birga, biznes qat'iy tartibga soluvchi talablar va plasebo xatarlarini yengib o'tish uchun o'zining yetkazib berish usullari bo'yicha patent himoyasiga tayanadi, bunda ko'rsatkich 0.31 darajasida turibdi.
Vistagen Therapeutics (VTGN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Vistagen Therapeutics|VTGN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati vistagen.com|VTGN - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati VistaGen Therapeutics Inc|VTGN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Vistagen|Tezkor likvidlik vistagen.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:VistaGen Therapeutics, Inc., VTGN
Investorlar Vistagen Therapeutics (VTGN) kompaniyasini uning innovatsion preparatini tijoratlashtirishga bo'lgan umidlari nuqtai nazaridan baholamoqdalar. Ushbu ko'rsatkich kelajakdagi o'sish uchun mukofotni aniqlash maqsadida kompaniyaning joriy bozor qiymatini sof aktivlari bilan taqqoslaydi. Bozorning balans kapitalini qayta baholash koeffitsientini tahlil qilish orqali kotirovkalarning 3-bosqich klinik sinovlaridagi muvaffaqiyatlar va qo'shilish va sotib olish istiqbollariga sezgirligini kuzatish mumkin. Ko'rsatkich bozorning intellektual mulk qiymatini qanchalik ishonchli baholayotganini ko'rsatadi, bu yuqori xavfli biotexnologik aktivlar uchun odatiy holdir.
Toʻgʻridan-toʻgʻri raqobatchilar
Biogen Inc. (BIIB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati NBIX|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|Kapitallashuvning sof aktivlarga nisbati AMLX|Bozor qiymatining balans qiymatiga nisbati TRVI|Bozor kapitallashuvining balans qiymatiga nisbati PRAX|Balans qiymatiga nisbatan bozor kapitallashuvi Anavex|Bozor qiymatining balans qiymatiga nisbati CeriBell Corp CBLL|Balans qiymatiga nisbatan bozor kapitallashuvi Prothena (PRTA)|ALEC: Kapitallashuvning sof aktivlarga nisbati|annexonbio.com - Bozor kapitallashuvining balans qiymatiga multiplikatori|OMER: Bozor kapitallashuvining balans qiymatiga nisbati|Neurogene Inc (NGNE) - Bozor kapitallashuvining balans qiymatiga nisbati|ACIU (AC Immune Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|VYGR - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati NMRA|SCLX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Tevogen Bio TVGN|ACOG: Kapitallashuvning balans qiymatiga nisbati|CGTX: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati IKT (Inhibikase Pharma)|SAVA (Cassava Sciences, Inc.) - Kapitallashuvning sof aktivlarga nisbati|ASRT: Bozor kapitallashuvining balans qiymatiga multiplikatori|COYA (Coya Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|OVID: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ABOS|CRVO - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Alterity Therapeutics Limited ATHE|Balans qiymatiga nisbatan bozor qiymati CLNN|PepGen Corp - Bozor kapitallashuvining balans qiymatiga nisbati|JUNS - Bozor kapitallashuvining balans qiymatiga nisbati|Relmada (RLMD) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ANVS (Annovis Bio Corporation)|GRCE (Grace Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti fireflyneuro.com AIFF|Kapitallashuvning sof aktivlarga nisbati KLTO (Klotho Neurosciences Inc)|Bozor kapitallashuvining balans qiymatiga nisbati neurosense-tx.com (NRSN)|Reviva Pharmaceuticals Holdings - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori MTVA (MetaVia Inc.)|NeurAxis, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Helius Medical HSDT|PASG: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Neuphoria Therapeutics|Bozor qiymatining balans qiymatiga nisbati Minerva Neurosciences Corp|Athira Pharma Corp (ATHA) - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati ADXN (Addex Therapeutics)|Bozor qiymatining balans qiymatiga nisbati ALZN (alzamend.com)|Cyclerion Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori PTIX (Protagenic Therapeutics Inc.)|Pasithea - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Cortigent, Inc. (CRGT)|Avenue Therapeutics (ATXI) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati BCLI|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics|Kapitallashuvning balans qiymatiga nisbati CHRO (Chromocell Therapeutics Corp)|Bozor kapitallashuvining balans qiymatiga nisbati ELYM|ITCI - Bozor qiymatining balans qiymatiga koeffitsiyenti|Longboard Pharmaceuticals - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati marinuspharma.com MRNS|NKGN - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati NRBO (NeuroBo Pharmaceuticals Inc)|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Synaptogenix, Inc (SNPX)|Kapitallashuvning sof aktivlarga nisbati TRVN|Bozor qiymatining balans qiymatiga nisbati VIGL|Bozor kapitallashuvining balans qiymatiga nisbati WENA|Balans qiymatiga nisbatan bozor kapitallashuvi Cerevel Therapeutics Inc